Monday, December 23 12:19:48
Merrion Pharmaceuticals plc has appointed John Fox as chief executive officer and a director with effect from January 1, 2014.
Fox is currently the company's chief development officer.
In addition, the board has appointed Michael McKenna as non-executive chairman. He is replacing Michael Donnelly who is stepping down from his current role as executive chairman. Donnelly will remain as a non-executive director of the company.
"These new appointments will both strengthen Merrion's operational capabilities and further enhance our links with the important United States market," said Merrion lead independent director Harry Stratford.